Cannae (NYSE:CNNE - Get Free Report) is projected to issue its Q1 2026 results after the market closes on Monday, May 11th. Analysts expect the company to announce earnings of ($0.40) per share and revenue of $99.7670 million for the quarter. Investors can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Monday, May 11, 2026 at 5:00 PM ET.
Cannae (NYSE:CNNE - Get Free Report) last issued its quarterly earnings data on Monday, February 23rd. The company reported ($1.93) earnings per share for the quarter, missing analysts' consensus estimates of ($0.38) by ($1.55). The firm had revenue of $103.30 million during the quarter, compared to analyst estimates of $102.70 million. Cannae had a negative return on equity of 31.78% and a negative net margin of 121.15%.The company's revenue was down 6.0% on a year-over-year basis. During the same quarter last year, the company posted ($0.74) EPS. On average, analysts expect Cannae to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Cannae Price Performance
Shares of Cannae stock traded down $0.01 during trading hours on Monday, reaching $13.67. The stock had a trading volume of 161,743 shares, compared to its average volume of 610,831. The stock's 50 day moving average is $12.13 and its 200 day moving average is $14.65. The firm has a market capitalization of $633.10 million, a PE ratio of -1.54 and a beta of 1.18. Cannae has a twelve month low of $10.46 and a twelve month high of $21.96. The company has a current ratio of 2.07, a quick ratio of 2.07 and a debt-to-equity ratio of 0.07.
Cannae Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 4.4%. The ex-dividend date was Tuesday, March 17th. Cannae's dividend payout ratio is -6.73%.
Analyst Ratings Changes
CNNE has been the subject of several research analyst reports. Stephens restated an "overweight" rating and set a $17.00 price target on shares of Cannae in a research report on Thursday, April 23rd. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Cannae in a research note on Wednesday, April 8th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and set a $17.00 price objective on shares of Cannae in a research note on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $17.00.
Read Our Latest Stock Analysis on CNNE
Institutional Investors Weigh In On Cannae
A number of hedge funds have recently added to or reduced their stakes in CNNE. Quantbot Technologies LP acquired a new stake in Cannae during the 2nd quarter worth approximately $62,000. Kelleher Financial Advisors acquired a new stake in Cannae during the 3rd quarter worth approximately $73,000. Bank of Montreal Can acquired a new stake in Cannae during the 4th quarter worth approximately $179,000. Cerity Partners LLC acquired a new stake in Cannae during the 4th quarter worth approximately $183,000. Finally, BTG Pactual Asset Management US LLC acquired a new stake in Cannae during the 4th quarter worth approximately $196,000. 88.12% of the stock is currently owned by institutional investors and hedge funds.
Cannae Company Profile
(
Get Free Report)
Cannae Holdings, Inc NYSE: CNNE is a publicly traded diversified holding company that focuses on partnering with and investing in businesses across a range of industry sectors. The company seeks to identify attractive opportunities in both private and public markets, leveraging its capital resources and management expertise to support operational growth and value creation. Cannae's investment strategy emphasizes companies in data and analytics, marketing services, healthcare technology, and payment processing.
Through its portfolio, Cannae holds controlling or significant minority stakes in companies that provide critical software, data and services to corporate clients.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cannae, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cannae wasn't on the list.
While Cannae currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.